Simon Fillatreau
B cell activation has traditionally been studied to identify the molecular pathways controlling their differentiation into antibody-producing cells. However, B cells can also regulate immune responses through antibody-independent mechanisms, notably by producing the cytokine interleukin-10 (IL-10). Despite increasing interest in the regulatory functions of B cells, the molecular pathways governing IL-10 expression in activated B cells remain incompletely understood. Many signals involved in general B cell activation contribute to IL-10 induction, suggesting that this response is intrinsically linked to the core machinery driving B cell activation, yet only a small fraction of B cells typically expresses IL-10 upon activation in vitro and in vivo. The distinct fate of activated B cells toward IL-10-producing versus non-producing states may reflect quantitative or qualitative differences in the activating signals they receive. A non-mutually exclusive possibility is that specific pathways, distinct from the core B cell activation program, selectively promote IL-10 expression in a subset of activated B cells. Defining these pathways is important because they could potentially be harnessed to suppress pathological immune responses or, conversely, be targeted to enhance protective immunity against tumors and pathogens. In this review, we examine the signals known to regulate IL-10 expression in B cells in the context of their broader roles in B cell activation and differentiation.